Bespoke Extracts (BSPK) EPS (Basic) Growth (3y) (2014 - 2025)
Bespoke Extracts (BSPK) EPS (Basic) Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 50.53% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.20% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -70.04% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -6.51% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 65.05% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -18.26% |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | -32.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -32.01% |
| Jun 30, 2025 | -85.55% |
| Mar 31, 2025 | 44.83% |
| Nov 30, 2021 | -77.75% |
| Aug 31, 2021 | 30.76% |
| May 31, 2021 | 73.55% |
| Feb 28, 2021 | 71.17% |
| Nov 30, 2020 | 70.34% |
| May 31, 2020 | 52.25% |
| Feb 29, 2020 | 29.76% |
| Nov 30, 2019 | 31.77% |
| Aug 31, 2019 | 35.51% |
| May 31, 2019 | 34.45% |
| Feb 28, 2019 | 45.89% |
| Nov 30, 2018 | 67.12% |
| Aug 31, 2018 | 32.52% |
| May 31, 2018 | -97.45% |
| Feb 28, 2018 | -59.63% |
| Nov 30, 2017 | -76.45% |
| Aug 31, 2017 | -80.23% |